Galderma Pharmaceutical Expands in Quebec
Location Canada 2010
Galderma, which produces the skin care line Cetaphil, received more than $38 million from Investissement Quebec, the province's investment program, which targets product development projects by Quebec companies. The sum includes a non-refundable $3.8 million financial contribution that will help Galderma modernize and expand its drug manufacturing plant in Bai-d'Urfe.
"The government's support was a decisive factor in Galderma's decision to locate its center of excellence in Quebec," says Michel Sauvageau, manager of the Bai-d'Urfe plant. "In response to the progress of emerging countries in biopharmaceuticals, this investment in our manufacturing facility will increase its capacity and make it truly state-of-the-art."
The funds will also allow Galderma to consolidate 240 positions and create 30 new, specialized jobs.
Project Announcements
E-One Moli Plans Maple Ridge, British Columbia, Manufacturing Operations
11/21/2023
Sweden-Based Northvolt Plans Quebec, Canada, Lithium Battery Gigafactory
10/02/2023
Martin Brower Plans Oshawa, Ontario, Canada, Distribution Hub
09/26/2023
Axium Packaging Plans Brampton, Ontario, Canada, Operations
09/05/2023
SK On-EcoProBM-Ford Plan Becancour, Quebec, Canada, Cathode Manufacturing Operations
08/23/2023
Newlight Technologies Plans Manitoba, Canada, AirCarbon Manufacturing Plant
08/07/2023
Most Read
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The Rise of Mid-Size U.S. Cities: The Industrial Development Boom
Q3 2023
-
Front Line: Brownfields Offer Redevelopment Opportunities
Q4 2023
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Immigration: A Potential Fix for Labor Shortages?
Workforce Q4 2023
-
2023 Top States Workforce Development Programs
Q3 2023